Meet the CohnReznick Team at JPM 2026
As a leading advisory firm in the life sciences sector, the CohnReznick team is excited to connect in San Francisco during the J.P. Morgan Healthcare Conference. Despite a challenging capital environment, we continue to see strong momentum from companies with compelling data and solid fundamentals.
Innovation across biotech, pharma, and health tech is creating real opportunities — and we’re here to help you navigate what’s next. We look forward to meaningful conversations at JPM 2026.
Who’s attending
Get to know the CohnReznick Life Sciences team and email directly to schedule a time to meet.
Kate Abdrashitova
Director,
CFO Advisory
Helps finance leaders optimize operations and prepare for strategic growth.
Alex Castelli
Partner,
Emerging Industries, Assurance
Executes assurance strategies for high-growth companies in emerging industries.
Mohammed Hasham
Partner,
West Region Leader,
Capital Markets & IPO
Supports companies in preparing for IPOs and accessing capital markets.
Greg Mochizuki
Partner,
Value360 - Transactional Advisory
Advises clients through complex transactions to maximize deal value and mitigate risk.
Sabrina Quinn
Director - Sales Leader,
Sales
Leads sales initiatives to connect clients with the right advisory expertise.
Ravi Raghunathan
Partner,
Assurance
Provides assurance services that strengthen financial reporting and compliance.
Mel Walker
Managing Director,
Data & AI Practice Leader,
Digital Advisory
Guides clients in leveraging data and AI to drive digital transformation.
Jason Zimmerman
Partner,
Assurance
Delivers audit and assurance services that support transparency and investor confidence.
Supporting emerging life sciences companies
and investors
CohnReznick’s Life Sciences team brings deep expertise across biotech, pharma, and health tech. We help companies accelerate growth, optimize operations, and prepare for investment and M&A opportunities.
Our team is uniquely positioned to support:
- Clinical innovation and trial strategy
- Capital markets readiness and investor engagement
- Regulatory and commercialization advisory
- Strategic transactions and M&A planning
Want to stay ahead of the curve?
We’ve pulled together insights on everything from global tax changes and R&D credit updates to IPO readiness and finance automation. Plus, we dive into de-SPAC strategies and how capital meets strategy for smarter growth. These quick reads are packed with practical tips to help you navigate what’s next.
OBBB: Top tax changes for multinational enterprises
Five focus areas for high-impact finance automation
PCAOB audit readiness for IPO and de-SPAC success
R&D credits: Meet new documentation standards
Going public as a SPAC target company: What to consider and how to prepare
Where capital meets strategy: Unpacking valuation, performance, & due diligence
"CohnReznick" is the brand name under which CohnReznick LLP and CohnReznick Advisory LLC and their respective subsidiaries provide professional services. CohnReznick LLP and CohnReznick Advisory LLC (and their respective subsidiaries) practice in an alternative practice structure in accordance with the AICPA Code of Professional Conduct and applicable law, regulations, and professional standards. CohnReznick LLP is a licensed CPA firm that provides attest services to its clients. CohnReznick Advisory LLC provides tax and business consulting services to its clients. CohnReznick Advisory LLC and its subsidiaries are not licensed CPA firms.
©2026 CohnReznick Advisory LLC, All Rights Reserved.
